Danielle joined Drug Discovery News as a freelance science writer in 2021. She earned her PhD from Yale University in 2017 and is currently a postdoctoral researcher at Weill Cornell Medicine where she studies the effects of early life stress on brain development. Danielle has written about many topics, including antimicrobial resistance, mitochondrial disease, and the first transgenic mice. In her spare time, Danielle enjoys baking, knitting, and hiking.
A novel, non-invasive treatment using electrical currents exploits physiological properties of dividing cancer cells to prolong survival and augment current therapies.
Recent advancements in mitochondrial genome editing technologies take scientists one step closer to developing viable treatments for mitochondrial diseases, which affect 1 in 4300 adults.
Scientists continue to ring alarm bells about the risks associated with the continued misuse of antimicrobials and advocate for innovative treatments, improved surveillance, and greater public health education.
Scientists found evidence of telomeres in the 1930s, but did not identify them until the 1970s. Since then, researchers’ understanding of telomeres and their role in DNA repair, aging, and disease has expanded exponentially.
Using a mouse model of breast cancer brain metastasis, researchers
showed that tumor cells require fatty acid synthesis to grow, which offers
a potential therapeutic target.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.